Deciphera Pharmaceuticals, Inc. (DCPH) Reaches $24.67 Formed H&S; Nuveen Real Estate Income Fund (JRS) Has 0.74 Sentiment

Nuveen Real Estate Income Fund (JRS) investors sentiment decreased to 0.74 in 2017 Q4. It’s down -1.26, from 2 in 2017Q3. The ratio has dropped, as 14 funds increased and opened new stock positions, while 19 sold and trimmed holdings in Nuveen Real Estate Income Fund. The funds in our database now possess: 2.82 million shares, down from 3.35 million shares in 2017Q3. Also, the number of funds holding Nuveen Real Estate Income Fund in top ten stock positions was flat from 0 to 0 for the same number . Sold All: 5 Reduced: 14 Increased: 8 New Position: 6.

Deciphera Pharmaceuticals, Inc. (DCPH) formed H&S with $23.68 target or 4.00% below today’s $24.67 share price. Deciphera Pharmaceuticals, Inc. (DCPH) has $804.10M valuation. The stock decreased 1.71% or $0.43 during the last trading session, reaching $24.67. About 53,836 shares traded. Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) has 0.00% since May 9, 2017 and is . It has underperformed by 11.55% the S&P500.

Analysts await Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) to report earnings on June, 27. After $-0.62 actual earnings per share reported by Deciphera Pharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts 1.61% negative EPS growth.

The stock decreased 0.20% or $0.02 during the last trading session, reaching $9.8. About 46,374 shares traded. Nuveen Real Estate Income Fund (JRS) has declined 13.65% since May 9, 2017 and is downtrending. It has underperformed by 25.20% the S&P500.

Whitnell & Co. holds 0.74% of its portfolio in Nuveen Real Estate Income Fund for 156,636 shares. Oxbow Advisors Llc owns 149,265 shares or 0.31% of their US portfolio. Moreover, Garrison Bradford & Associates Inc has 0.14% invested in the company for 15,500 shares. The Tennessee-based Summit Asset Management Llc has invested 0.08% in the stock. Clough Capital Partners L P, a Massachusetts-based fund reported 69,457 shares.

Nuveen Real Estate Income Fund is a closed-ended equity mutual fund launched by Nuveen Investments Inc. The company has market cap of $283.15 million. The fund is managed by Security Capital Research & Management Incorporated. It currently has negative earnings. It invests in the public equity markets of the United States.

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Ratings Chart

Free Email Newsletter

Enter your email address below to get the latest news and analysts’ ratings for your stocks with our free daily email newsletter: